N. G. Nuñez Et Al. , "Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors," Med , vol.4, no.2, pp.113, 2023
Nuñez, N. G. Et Al. 2023. Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. Med , vol.4, no.2 , 113.
Nuñez, N. G., Berner, F., Friebel, E., Unger, S., Wyss, N., Gomez, J. M., ... Purde, M.(2023). Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. Med , vol.4, no.2, 113.
Nuñez, Nicolas Et Al. "Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors," Med , vol.4, no.2, 113, 2023
Nuñez, Nicolas G. Et Al. "Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors." Med , vol.4, no.2, pp.113, 2023
Nuñez, N. G. Et Al. (2023) . "Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors." Med , vol.4, no.2, p.113.
@article{article, author={Nicolas Gonzalo Nuñez Et Al. }, title={Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors}, journal={Med}, year=2023, pages={113} }